Fresh Tracks Therapeutics (FRTX) Competitors $0.74 0.00 (-0.34%) (As of 12/20/2024 05:18 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrends FRTX vs. APRE, MEIP, SYBX, BTAI, BLRX, ATHE, CYTH, PRPH, FLGC, and SPRBShould you be buying Fresh Tracks Therapeutics stock or one of its competitors? The main competitors of Fresh Tracks Therapeutics include Aprea Therapeutics (APRE), MEI Pharma (MEIP), Synlogic (SYBX), BioXcel Therapeutics (BTAI), BioLineRx (BLRX), Alterity Therapeutics (ATHE), Cyclo Therapeutics (CYTH), ProPhase Labs (PRPH), Flora Growth (FLGC), and Spruce Biosciences (SPRB). These companies are all part of the "pharmaceutical products" industry. Fresh Tracks Therapeutics vs. Aprea Therapeutics MEI Pharma Synlogic BioXcel Therapeutics BioLineRx Alterity Therapeutics Cyclo Therapeutics ProPhase Labs Flora Growth Spruce Biosciences Fresh Tracks Therapeutics (NASDAQ:FRTX) and Aprea Therapeutics (NASDAQ:APRE) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, earnings, risk, media sentiment, profitability, dividends, analyst recommendations and valuation. Is FRTX or APRE more profitable? Fresh Tracks Therapeutics has a net margin of 0.00% compared to Aprea Therapeutics' net margin of -1,029.50%. Fresh Tracks Therapeutics' return on equity of 0.00% beat Aprea Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Fresh Tracks TherapeuticsN/A N/A N/A Aprea Therapeutics -1,029.50%-57.86%-47.94% Do analysts rate FRTX or APRE? Aprea Therapeutics has a consensus price target of $15.50, indicating a potential upside of 408.20%. Given Aprea Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Aprea Therapeutics is more favorable than Fresh Tracks Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fresh Tracks Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Aprea Therapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable earnings and valuation, FRTX or APRE? Fresh Tracks Therapeutics has higher revenue and earnings than Aprea Therapeutics. Aprea Therapeutics is trading at a lower price-to-earnings ratio than Fresh Tracks Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFresh Tracks Therapeutics$10.06M0.44-$5.69M-$1.41-0.52Aprea Therapeutics$580K28.58-$14.29M-$2.81-1.09 Does the media favor FRTX or APRE? In the previous week, Aprea Therapeutics had 2 more articles in the media than Fresh Tracks Therapeutics. MarketBeat recorded 3 mentions for Aprea Therapeutics and 1 mentions for Fresh Tracks Therapeutics. Aprea Therapeutics' average media sentiment score of 0.19 beat Fresh Tracks Therapeutics' score of -0.71 indicating that Aprea Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fresh Tracks Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative Aprea Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders and institutionals hold more shares of FRTX or APRE? 25.0% of Fresh Tracks Therapeutics shares are owned by institutional investors. Comparatively, 34.2% of Aprea Therapeutics shares are owned by institutional investors. 0.2% of Fresh Tracks Therapeutics shares are owned by company insiders. Comparatively, 12.8% of Aprea Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer FRTX or APRE? Aprea Therapeutics received 54 more outperform votes than Fresh Tracks Therapeutics when rated by MarketBeat users. Likewise, 56.25% of users gave Aprea Therapeutics an outperform vote while only 0.00% of users gave Fresh Tracks Therapeutics an outperform vote. CompanyUnderperformOutperformFresh Tracks TherapeuticsOutperform VotesNo VotesUnderperform Votes1100.00% Aprea TherapeuticsOutperform Votes5456.25% Underperform Votes4243.75% Which has more volatility & risk, FRTX or APRE? Fresh Tracks Therapeutics has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500. Comparatively, Aprea Therapeutics has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500. SummaryAprea Therapeutics beats Fresh Tracks Therapeutics on 11 of the 18 factors compared between the two stocks. Ad InvestorPlaceWall Street Icon: “You must get on the right side of this thing”I created one of the first quantitative analysis-based stock picking systems long before "quants" became a thing on Wall Street… leading Forbes to call me "King of the Quants." I'm writing to you today because my system has recently uncovered a market phenomenon I haven't seen in 30 years.This market shakeup is going to be much more intense. Get Fresh Tracks Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FRTX vs. The Competition Export to ExcelMetricFresh Tracks TherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.42M$2.94B$5.14B$9.08BDividend YieldN/A1.90%5.09%4.23%P/E Ratio-0.5245.9489.7417.16Price / Sales0.44415.011,117.09117.04Price / CashN/A182.1043.1037.86Price / Book0.453.894.784.78Net Income-$5.69M-$42.21M$120.31M$225.60M7 Day Performance-1.33%-2.15%-1.92%-1.23%1 Month Performance3.50%1.73%13.65%0.46%1 Year Performance-7.50%16.36%28.34%15.24% Fresh Tracks Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FRTXFresh Tracks TherapeuticsN/A$0.74-0.3%N/A-9.8%$4.42M$10.06M-0.5220APREAprea Therapeutics3.1914 of 5 stars$3.26+2.2%$15.50+375.5%-19.9%$17.72M$580,000.00-1.147Analyst ForecastNews CoverageMEIPMEI Pharma3.9163 of 5 stars$2.63-2.6%$7.00+166.2%-59.3%$17.52M$65.30M-0.39100Analyst ForecastSYBXSynlogicN/A$1.49-1.0%N/A-53.1%$17.37M$3.37M-0.366BTAIBioXcel Therapeutics3.9882 of 5 stars$0.41-1.4%$5.00+1,130.3%-88.5%$17.37M$2.28M-0.1790Negative NewsGap DownHigh Trading VolumeBLRXBioLineRx2.3143 of 5 stars$0.21-4.8%$9.00+4,105.6%-87.8%$17.11M$21.99M-1.0240Analyst ForecastHigh Trading VolumeATHEAlterity Therapeutics2.5794 of 5 stars$2.31-3.8%$6.00+159.7%-15.4%$16.86MN/A0.0010News CoverageCYTHCyclo Therapeutics3.2001 of 5 stars$0.58+0.0%$0.95+63.8%-65.2%$16.69M$870,725.00-0.649News CoveragePRPHProPhase Labs3.1815 of 5 stars$0.69+5.4%$11.00+1,503.5%-86.8%$16.38M$12.75M-0.57130High Trading VolumeFLGCFlora Growth3.0907 of 5 stars$1.22-6.2%$5.00+309.8%-21.6%$16.31M$64.15M0.00280Positive NewsGap DownHigh Trading VolumeSPRBSpruce Biosciences3.8134 of 5 stars$0.39+1.4%$3.90+903.3%-80.5%$16.05M$10.09M-0.4120Analyst Revision Related Companies and Tools Related Companies Aprea Therapeutics Alternatives MEI Pharma Alternatives Synlogic Alternatives BioXcel Therapeutics Alternatives BioLineRx Alternatives Alterity Therapeutics Alternatives Cyclo Therapeutics Alternatives ProPhase Labs Alternatives Flora Growth Alternatives Spruce Biosciences Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:FRTX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fresh Tracks Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fresh Tracks Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
